{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:23:27Z","timestamp":1793924607313,"version":"4.8.0"},"reference-count":165,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.bmc.2023.117187","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T20:43:30Z","timestamp":1674852210000},"page":"117187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-1416","authenticated-orcid":false,"given":"Gautam","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Kiran Tudu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117187_b0005","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.ajic.2016.05.009","article-title":"Risk factors for the development of active methicillin-resistant Staphylococcus aureus (MRSA) infection in patients colonized with MRSA at hospital admission","volume":"44","author":"Cadena","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.bmc.2023.117187_b0010","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/jam.13258","article-title":"Inhibition of the NorA efflux pump of Staphylococcus aureus by synthetic riparins","volume":"121","author":"Costa","year":"2016","journal-title":"J Appl Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0015","first-page":"59","article-title":"MRSA in equine hospitals and its significance for infections in humans","volume":"2017","author":"Cuny","year":"2015","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/2193-1801-2-283","article-title":"Comparison of clinical features and outcomes of staphylococcus aureus vertebral osteomyelitis caused by methicillin-resistant and methicillin-sensitive strains","volume":"2","author":"Inoue","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.bmc.2023.117187_b0025","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus Infections : Epidemiology, Pathophysiology, Clinical Manifestations, and Management","volume":"623","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2023.117187_b0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections-United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.bmc.2023.117187_b0035","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/cid\/cit020","article-title":"The global spread of healthcare-associated multidrug-resistant bacteria: A perspective from Asia","volume":"56","author":"Molton","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2023.117187_b0040","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1073\/pnas.0710217105","article-title":"Epidemic community-associated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification","volume":"105","author":"Kennedy","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117187_b0045","doi-asserted-by":"crossref","first-page":"9107","DOI":"10.1073\/pnas.1202869109","article-title":"Molecular tracing of the emergence, adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus","volume":"109","author":"McAdam","year":"2012","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117187_b0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MRM.0000000000000067","article-title":"A review of virulence factors, pathogenesis, and antibiotic resistance in Staphylococcus aureus","volume":"27","author":"Al-Mebairik","year":"2016","journal-title":"Rev Res Med Microbiol."},{"key":"10.1016\/j.bmc.2023.117187_b0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3389\/fcimb.2012.00056","article-title":"Host- and microbe determinants that may influence the success of S. aureus colonization","volume":"2","author":"Johannessen","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2020.00107","article-title":"Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus","volume":"10","author":"Guo","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0070","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1749-6632.2012.06819.x","article-title":"Mechanisms of daptomycin resistance in Staphylococcus aureus: Role of the cell membrane and cell wall","volume":"1277","author":"Bayer","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bmc.2023.117187_b0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jac\/dks354","article-title":"The emerging problem of linezolid-resistant Staphylococcus","volume":"68","author":"Gu","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0080","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0034-1397040","article-title":"Treatment of methicillin-resistant Staphylococcus aureus: Vancomycin and beyond","volume":"36","author":"Holmes","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.bmc.2023.117187_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkx349","article-title":"Daptomycin","volume":"73","author":"Heidary","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0090","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/cid\/civ528","article-title":"Skin and Soft-Tissue Infections: A Critical Review and the Role of Telavancin in Their Treatment","volume":"61","author":"Cardona","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2023.117187_b0095","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.2147\/IDR.S254395","article-title":"Ceftobiprole for treatment of MRSA blood stream infection: A case series","volume":"13","author":"Mahmoud","year":"2020","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.bmc.2023.117187_b0100","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/14787210.2019.1667229","article-title":"Ceftobiprole: drug evaluation and place in therapy","volume":"17","author":"Giacobbe","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bmc.2023.117187_b0105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/1120009X.2017.1351729","article-title":"Ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case series","volume":"30","author":"Lalikian","year":"2018","journal-title":"J Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.diagmicrobio.2012.12.004","article-title":"Tigecycline: An update","volume":"75","author":"Stein","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2023.117187_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofy331","article-title":"Dalbavancin for the treatment of osteomyelitis in adult patients: A randomized clinical trial of efficacy and safety","volume":"6","author":"Rappo","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bmc.2023.117187_b0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ijantimicag.2017.11.008","article-title":"Dalbavancin in the treatment of different gram-positive infections: a real-life experience","volume":"51","author":"Bouza","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2023.117187_b0125","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/14656566.2018.1519021","article-title":"An evaluation of tedizolid for the treatment of MRSA infections","volume":"19","author":"Hall","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bmc.2023.117187_b0130","first-page":"189","article-title":"Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms","volume":"2020","author":"Guo","year":"2019","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.bmc.2023.117187_b0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/17512433.2020.1774362","article-title":"Tedizolid (torezolid) for the treatment of complicated skin and skin structure infections","volume":"13","author":"Carena","year":"2020","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.bmc.2023.117187_b0140","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/14787210.2018.1489721","article-title":"Delafloxacin: a novel fluoroquinolone with activity against methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa","volume":"16","author":"Ocheretyaner","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bmc.2023.117187_b0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tips.2015.11.008","article-title":"Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections","volume":"37","author":"Sause","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2023.117187_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/v11010088","article-title":"Design and preclinical development of a phage product for the treatment of antibiotic-resistant staphylococcus aureus infections","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117187_b0155","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-020-01891-8","article-title":"Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus","volume":"20","author":"Kifelew","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/antib7010005","article-title":"Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections","volume":"7","author":"Wang-Lin","year":"2018","journal-title":"Antibodies"},{"key":"10.1016\/j.bmc.2023.117187_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0190537","article-title":"A natural human monoclonal antibody targeting Staphylococcus Protein A protects against Staphylococcus aureus bacteremia","volume":"13","author":"Varshney","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117187_b0175","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","article-title":"Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned","volume":"30","author":"van Duin","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bmc.2023.117187_b0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/antibiotics2010028","article-title":"Recent advances in Multi-Drug Resistance (MDR) efflux pump inhibitors of Gram-positive bacteria S. aureus","volume":"2","author":"Handzlik","year":"2013","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117187_b0185","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.3389\/fmicb.2015.00034","article-title":"Mechanisms of antibiotic resistance","volume":"6","author":"Lin","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.bmc.2023.117187_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12275-016-5159-z","article-title":"Multidrug efflux pumps in Staphylococcus aureus and their clinical implications","volume":"54","author":"Jang","year":"2016","journal-title":"J Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0200","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/ijerph120201487","article-title":"Multidrug efflux pumps from enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens","volume":"12","author":"Andersen","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.bmc.2023.117187_b0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3390\/plants6020016","article-title":"Antimicrobial resistance and the alternative resources with special emphasis on plant-based antimicrobials - A review","volume":"6","author":"Chandra","year":"2017","journal-title":"Plants."},{"key":"10.1016\/j.bmc.2023.117187_b0210","article-title":"Efflux pump inhibitors\u00a0: new updates","author":"Almatar","year":"2020","journal-title":"Pharmacol Reports"},{"key":"10.1016\/j.bmc.2023.117187_b0215","first-page":"1","volume":"2019","author":"Lamut","year":"2018","journal-title":"Efflux pump inhibitors of clinically relevant multidrug resistant bacteria."},{"key":"10.1016\/j.bmc.2023.117187_b0220","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cmdc.201000006","article-title":"Efflux pump inhibitors: A strategy to combat P-glycoprotein and the NorA multidrug resistance pump","volume":"5","author":"Zhang","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117187_b0225","first-page":"512","article-title":"Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update","volume":"12","author":"Blair","year":"2009","journal-title":"CurrentOpinion in Microbiology"},{"key":"10.1016\/j.bmc.2023.117187_b0230","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2217\/fmb-2019-0235","article-title":"RND efflux pumps in Gram-negative bacteria; Regulation, structure and role in antibiotic resistance","volume":"15","author":"Colclough","year":"2020","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/microorganisms4010014","article-title":"Bacterial multidrug efflux pumps: Much more than antibiotic resistance determinants","volume":"4","author":"Blanco","year":"2016","journal-title":"Microorganisms."},{"key":"10.1016\/j.bmc.2023.117187_b0240","article-title":"A comprehensive review on pharmacology of efflux pumps and their inhibitors in antibiotic resistance","volume":"2021","author":"Thakur","year":"2020","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.bmc.2023.117187_b0245","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41589-022-00999-4","article-title":"A (Fab)ulous tool to block efflux","volume":"18","author":"Penmatsa","year":"2022","journal-title":"Nature Chem Biol"},{"key":"10.1016\/j.bmc.2023.117187_b0250","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijmm.2009.10.005","article-title":"An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway","volume":"300","author":"Schneider","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0255","doi-asserted-by":"crossref","first-page":"14440","DOI":"10.1002\/anie.201804971","article-title":"Thinking Outside the Box\u2014Novel Antibacterials To Tackle the Resistance Crisis","volume":"57","author":"Lakemeyer","year":"2018","journal-title":"Angew Chemie - Int Ed."},{"key":"10.1016\/j.bmc.2023.117187_b0260","first-page":"1","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat Rev Dis Prim."},{"key":"10.1016\/j.bmc.2023.117187_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2017.03.001","article-title":"New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus","volume":"31","author":"Assis","year":"2017","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bmc.2023.117187_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.04.003","article-title":"Multidrug efflux pumps of Gram-positive bacteria","volume":"27","author":"Schindler","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.bmc.2023.117187_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26226996","article-title":"Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives","volume":"26","author":"Cernicchi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117187_b0280","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/j.bmcl.2017.08.027","article-title":"Antibiotic adjuvants-A strategy to unlock bacterial resistance to antibiotics","volume":"27","author":"Gonz\u00e1lez-Bello","year":"2017","journal-title":"Bioorganic Med Chem Lett."},{"issue":"118","key":"10.1016\/j.bmc.2023.117187_b0285","article-title":"Review on plant antimicrobials\u00a0: a mechanistic viewpoint","volume":"8","author":"Khameneh","year":"2019","journal-title":"Antimicrob Resist Infection Control"},{"key":"10.1016\/j.bmc.2023.117187_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104225","article-title":"Bioorganic Chemistry Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors","volume":"104","author":"Kumar","year":"2020","journal-title":"Bioorg Chem"},{"issue":"4","key":"10.1016\/j.bmc.2023.117187_b0295","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2217\/fmb.13.16","article-title":"Inhibition of drug efflux pumps in Staphylococcus aureus: current status of potentiating existing antibiotics Bryan","volume":"8","author":"Schindler","year":"2013","journal-title":"Futur Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0300","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1021\/acs.jmedchem.6b01439","article-title":"Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors","volume":"60","author":"Astolfi","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0305","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.2147\/IDR.S201124","article-title":"A novel mechanism of action of ketoconazole: Inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant staphylococcus aureus","volume":"12","author":"El-Baky","year":"2019","journal-title":"Infect Drug Resist."},{"key":"10.1016\/j.bmc.2023.117187_b0310","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"F\u00e0brega","year":"2009","journal-title":"J Microbial Biotechnol"},{"key":"10.1016\/j.bmc.2023.117187_b0315","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/14787210.6.5.685","article-title":"Plasmid-mediated quinolone resistance","volume":"6","author":"Mart\u00ednez-Mart\u00ednez","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.bmc.2023.117187_b0320","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/femsre\/fux007","article-title":"Antibiotic resistance in Staphylococcus aureus. Current status and future prospects","volume":"41","author":"Foster","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.bmc.2023.117187_b0325","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/cmdc.201900688","article-title":"Synthesis and Evaluation of 2-Aminothiophene Derivatives as Staphylococcus aureus Efflux Pump Inhibitors","volume":"15","author":"da Cruz","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117187_b0330","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mimet.2017.09.001","article-title":"Optimized efflux assay for the NorA multidrug efflux pump in Staphylococcus aureus","volume":"142","author":"Zimmermann","year":"2017","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.bmc.2023.117187_b0335","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.apsb.2016.06.003","article-title":"The modification of natural products for medical use","volume":"7","author":"Guo","year":"2017","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.bmc.2023.117187_b0340","first-page":"263","article-title":"Plant secondary metabolites: From molecular biology to health products","author":"De Filippis","year":"2015","journal-title":"Plant-Environment Interact Responses Approaches to Mitigate Stress."},{"key":"10.1016\/j.bmc.2023.117187_b0345","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1128\/microbiolspec.FUNK-0009-2016","article-title":"Biologically Active Secondary Metabolites from the Fungi","volume":"4","author":"Bills","year":"2016","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.bmc.2023.117187_b0350","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jarmap.2015.09.002","article-title":"Impact of various factors responsible for fluctuation in plant secondary metabolites","volume":"2","author":"Verma","year":"2015","journal-title":"Journal of Applied Research on Medicinal and Aromatic Plants"},{"key":"10.1016\/j.bmc.2023.117187_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10121502","article-title":"Efflux pump mediated antimicrobial resistance by staphylococci in health-related environments: Challenges and the quest for inhibition","volume":"10","author":"Dashtbani-Roozbehani","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117187_b0360","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpha.2019.11.002","article-title":"Plant-derived secondary metabolites as the main source of efflux pump inhibitors and methods for identification","volume":"10","author":"Seukep","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.bmc.2023.117187_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2018.02990","article-title":"Inhibiting bacterial drug efflux pumps via phyto-therapeutics to combat threatening antimicrobial resistance","volume":"9","author":"Shriram","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0370","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.030540597","article-title":"Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5\u2032-methoxyhydnocarpin, a multidrug pump inhibitor","volume":"97","author":"Stermitz","year":"2000","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117187_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0018127","article-title":"Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria","volume":"6","author":"Fiamegos","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2023.117187_b0380","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1055\/s-2002-36347","article-title":"Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus","volume":"68","author":"Stermitz","year":"2002","journal-title":"Planta Med"},{"key":"10.1016\/j.bmc.2023.117187_b0385","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1016\/j.bmc.2018.05.017","article-title":"Elucidating the inhibition of peptidoglycan biosynthesis in Staphylococcus aureus by albocycline, a macrolactone isolated from Streptomyces maizeus","volume":"26","author":"Liang","year":"2018","journal-title":"Bioorganic Med Chem."},{"key":"10.1016\/j.bmc.2023.117187_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.115995","article-title":"Staphylococcus aureus resistance to albocycline can be achieved by mutations that alter cellular NAD\/PH pools","volume":"32","author":"Scherzi","year":"2021","journal-title":"Bioorganic Med Chem."},{"issue":"10","key":"10.1016\/j.bmc.2023.117187_b0395","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1039\/C9FO01233H","article-title":"Destruction of the cell membrane and inhibition of cell phosphatidic acid biosynthesis in: Staphylococcus aureus: An explanation for the antibacterial mechanism of morusin","volume":"10","author":"Pang","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.bmc.2023.117187_b0400","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1021\/acs.jafc.9b01795","article-title":"Natural Flavones from Morus alba against Methicillin-Resistant Staphylococcus aureus via Targeting the Proton Motive Force and Membrane Permeability","volume":"67","author":"Wu","year":"2019","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.01450-19","article-title":"Pyrrolomycins are potent natural protonophores","volume":"63","author":"Valderrama","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0410","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tifs.2019.07.038","article-title":"Dihydromyricetin: A review on identification and quantification methods, biological activities, chemical stability, metabolism and approaches to enhance its bioavailability","volume":"91","author":"Liu","year":"2019","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.bmc.2023.117187_b0415","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.foodchem.2016.07.090","article-title":"A dual antibacterial mechanism involved in membrane disruption and DNA binding of 2R,3R-dihydromyricetin from pine needles of Cedrus deodara against Staphylococcus aureus","volume":"218","author":"Wu","year":"2017","journal-title":"Food Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.02341","article-title":"Balsacone c, a new antibiotic targeting bacterial cell membranes, inhibits clinical isolates of methicillin-resistant Staphylococcus aureus (Mrsa) without inducing resistance","volume":"10","author":"C\u00f4t\u00e9","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115151","article-title":"The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteria","volume":"27","author":"Meier","year":"2019","journal-title":"Bioorganic Med Chem."},{"key":"10.1016\/j.bmc.2023.117187_b0430","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1039\/C7IB00095B","article-title":"Membrane and genomic DNA dual-targeting of citrus flavonoid naringenin against: Staphylococcus aureus","volume":"9","author":"Wang","year":"2017","journal-title":"Integr Biol (United Kingdom)."},{"key":"10.1016\/j.bmc.2023.117187_b0435","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.freeradbiomed.2015.06.016","article-title":"A polyphenolic flavonoid glabridin: Oxidative stress response in multidrug-resistant Staphylococcus aureus","volume":"87","author":"Singh","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bmc.2023.117187_b0440","article-title":"Inhibition of multidrug-resistant foodborne Staphylococcus aureus biofilms by a natural terpenoid (+)-nootkatone and related molecular mechanism","volume":"2020","author":"Farha","year":"2019","journal-title":"Food Control"},{"key":"10.1016\/j.bmc.2023.117187_b0445","first-page":"1940","article-title":"Azalomycin F5a, a polyhydroxy macrolide binding to the polar head of phospholipid and targeting to lipoteichoic acid to kill methicillin-resistant Staphylococcus aureus","volume":"2019","author":"Yuan","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2023.117187_b0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21030862","article-title":"Azalomycin F5a eradicates Staphylococcus aureus biofilm by rapidly penetrating and subsequently inducing cell lysis","volume":"21","author":"Yuan","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117187_b0455","doi-asserted-by":"crossref","first-page":"10636","DOI":"10.1002\/ange.201915407","article-title":"The Kalimantacin Polyketide Antibiotics Inhibit Fatty Acid Biosynthesis in Staphylococcus aureus by Targeting the Enoyl-Acyl Carrier Protein Binding Site of FabI","volume":"132","author":"Fage","year":"2020","journal-title":"Angew Chemie."},{"key":"10.1016\/j.bmc.2023.117187_b0460","doi-asserted-by":"crossref","first-page":"10124","DOI":"10.1073\/pnas.1807613115","article-title":"Amycomicin is a potent and specific antibiotic discovered with a targeted interaction screen","volume":"115","author":"Pishchany","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117187_b0465","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijantimicag.2018.04.024","article-title":"Plant nutraceuticals as antimicrobial agents in food preservation: terpenoids, polyphenols and thiols","volume":"52","author":"Guti\u00e9rrez-del-R\u00edo","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2023.117187_b0470","first-page":"1","article-title":"Effect of \u03b1-bisabolol and its \u03b2-cyclodextrin complex as TetK and NorA efflux pump inhibitors in Staphylococcus aureus strains","volume":"9","author":"da Cruz","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117187_b0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sajb.2021.07.046","article-title":"Phytochemical characterization and antibiotic potentiating effects of the essential oil of Aloysia gratissima (Gillies & Hook.) and beta-caryophyllene","volume":"143","author":"Santos","year":"2021","journal-title":"South African J Bot."},{"key":"10.1016\/j.bmc.2023.117187_b0480","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.phymed.2016.03.001","article-title":"A clerodane diterpene from Polyalthia longifolia as a modifying agent of the resistance of methicillin resistant Staphylococcus aureus","volume":"23","author":"Gupta","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2023.117187_b0485","first-page":"1","article-title":"In silico and in vitro evaluation of efflux pumps inhibition of \u03b1, \u03b2-amyrin","author":"Oliveira","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2023.117187_b0490","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10863-021-09906-3","article-title":"Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains","volume":"53","author":"dos Santos Barbosa","year":"2021","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.bmc.2023.117187_b0495","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1007\/s00284-021-02611-9","article-title":"In Vitro and In Silico Inhibition of Staphylococcus aureus Efflux Pump NorA by \u03b1-Pinene and Limonene","volume":"78","author":"de Ara\u00fajo","year":"2021","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0500","article-title":"In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus","volume":"2021","author":"Muniz","year":"2020","journal-title":"Food Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0505","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.micpath.2016.08.026","article-title":"Inhibition of the NorA multi-drug transporter by oxygenated monoterpenes","volume":"99","author":"Co\u00ealho","year":"2016","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2023.117187_b0510","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1007\/s00203-021-02347-x","article-title":"Evaluation of antibacterial activity and reversal of the NorA and MepA efflux pump of estragole against Staphylococcus aureus bacteria","volume":"203","author":"da Costa","year":"2021","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0515","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.bbamem.2015.10.018","article-title":"Biochimica et Biophysica Acta Molecular mechanisms of membrane targeting antibiotics","volume":"1858","author":"Epand","year":"2016","journal-title":"BBA - Biomembr."},{"key":"10.1016\/j.bmc.2023.117187_b0520","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11101-018-9591-z","article-title":"Comprehensive review of antimicrobial activities of plant flavonoids","volume":"18","author":"G\u00f3rniak","year":"2019","journal-title":"Phytochem Rev"},{"key":"10.1016\/j.bmc.2023.117187_b0525","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jiac.2014.08.001","article-title":"Multi-drug-resistant Staphylococcus aureus and future chemotherapy","volume":"20","author":"Hiramatsu","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0530","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.copbio.2011.08.007","article-title":"Polyphenols as antimicrobial agents","volume":"23","author":"Daglia","year":"2012","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.bmc.2023.117187_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2020.104720","article-title":"Antimicrobial flavonoids as a potential substitute for overcoming antimicrobial resistance","volume":"146","author":"Biharee","year":"2020","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bmc.2023.117187_b0540","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/ptr.5098","article-title":"Flavonoids from Sophora moorcroftiana and their synergistic antibacterial effects on MRSA","volume":"28","author":"Wang","year":"2014","journal-title":"Phyther Res."},{"key":"10.1016\/j.bmc.2023.117187_b0545","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jep.2011.06.039","article-title":"Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase","volume":"137","author":"Chan","year":"2011","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.bmc.2023.117187_b0550","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-0032-1328259","article-title":"Sarothrin from Alkanna orientalis is an antimicrobial agent and efflux pump inhibitor","volume":"79","author":"Bame","year":"2013","journal-title":"Planta Med"},{"key":"10.1016\/j.bmc.2023.117187_b0555","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10863-021-09886-4","article-title":"Enhancement of the antibiotic activity by quercetin against Staphylococcus aureus efflux pumps","volume":"53","author":"dos Santos","year":"2021","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.bmc.2023.117187_b0560","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.lwt.2016.04.003","article-title":"Fruit flavonoids as modulators of norfloxacin resistance in Staphylococcus aureus that overexpresses norA","volume":"85","author":"Diniz-Silva","year":"2017","journal-title":"LWT - Food Sci Technol."},{"key":"10.1016\/j.bmc.2023.117187_b0565","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.sajb.2020.03.023","article-title":"Structural characterization, antibacterial activity and NorA efflux pump inhibition of flavonoid fisetinidol","volume":"132","author":"da Silva","year":"2020","journal-title":"South African J Bot."},{"key":"10.1016\/j.bmc.2023.117187_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106098","article-title":"Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus","volume":"56","author":"Sun","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2023.117187_b0575","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1080\/14786419.2019.1639182","article-title":"Flavonoids from Artemisia rupestris and their synergistic antibacterial effects on drug-resistant Staphylococcus aureus","volume":"35","author":"Lan","year":"2021","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmc.2023.117187_b0580","first-page":"484","article-title":"Efflux pump inhibitory activity of flavonoids isolated from Alpinia calcarata against methicillin-resistant Staphylococcus aureus","volume":"71","author":"Randhawa","year":"2016","journal-title":"Biol"},{"key":"10.1016\/j.bmc.2023.117187_b0585","doi-asserted-by":"crossref","first-page":"61881","DOI":"10.1039\/C5RA07165H","article-title":"Dual role of pinostrobin-a flavonoid nutraceutical as an efflux pump inhibitor and antibiofilm agent to mitigate food borne pathogens","volume":"5","author":"Christena","year":"2015","journal-title":"RSC Adv"},{"issue":"5","key":"10.1016\/j.bmc.2023.117187_b0590","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jac\/dks005","article-title":"Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees","volume":"67","author":"Holler","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0595","article-title":"Lignans and Stilbenes from African Medicinal Plants","author":"Tsopmo","year":"2013","journal-title":"Elsevier Inc."},{"key":"10.1016\/j.bmc.2023.117187_b0600","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/b514045p","article-title":"An update on bioactive plant lignans","volume":"22","author":"Saleem","year":"2005","journal-title":"Nat Prod Rep"},{"issue":"October","key":"10.1016\/j.bmc.2023.117187_b0605","first-page":"1","article-title":"A Review of the Phytochemistry and Pharmacology of Phyllanthus","volume":"9","author":"Ding","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2023.117187_b0610","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.micpath.2019.03.012","article-title":"Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by Phyllanthin","volume":"130","author":"Braga Ribeiro","year":"2019","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2023.117187_b0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112806","article-title":"Flavonolignans from silymarin modulate antibiotic resistance and virulence in Staphylococcus aureus","volume":"149","author":"Holasov\u00e1","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2023.117187_b0620","first-page":"827","article-title":"Inhibitory effects of silybin on the efflux pump of methicillin-resistant Staphylococcus aureus","volume":"18","author":"Wang","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.bmc.2023.117187_b0625","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acs.jafc.9b00694","article-title":"Defying Multidrug Resistance! Modulation of Related Transporters by Flavonoids and Flavonolignans","volume":"68","author":"Chambers","year":"2020","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0630","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox9050455","article-title":"Multidrug Resistance Modulation Activity of Silybin Derivatives and Their Anti-Inflammatory Potential","volume":"9","author":"Dobiasov\u00e1","year":"2020","journal-title":"Antioxidants."},{"key":"10.1016\/j.bmc.2023.117187_b0635","doi-asserted-by":"crossref","first-page":"43518","DOI":"10.1039\/C6RA10199B","article-title":"Benzocyclohexane oxide derivatives and neolignans from: Piper betle inhibit efflux-related resistance in Staphylococcus aureus","volume":"6","author":"Sun","year":"2016","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117187_b0640","doi-asserted-by":"crossref","first-page":"11072","DOI":"10.1021\/acs.joc.0c02682","article-title":"Neolignans from Piper betle Have Synergistic Activity against Antibiotic-Resistant Staphylococcus aureus","volume":"86","author":"Xiao","year":"2021","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0645","article-title":"An insight into the therapeutic applications of coumarin compounds and their mechanisms of action","volume":"2020","author":"Garg","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.bmc.2023.117187_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112832","article-title":"Antibacterial activities with the structure-activity relationship of coumarin derivatives","volume":"207","author":"Qin","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.201900380","article-title":"Coumarin-containing hybrids and their antibacterial activities","volume":"353","author":"Feng","year":"2020","journal-title":"Arch Pharm (Weinheim)."},{"key":"10.1016\/j.bmc.2023.117187_b0660","volume":"Vol 90","author":"Roy","year":"2013","journal-title":"NorA Efflux Pump Inhibitory Activity of Coumarins from Mesua Ferrea"},{"key":"10.1016\/j.bmc.2023.117187_b0665","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.micpath.2017.01.028","article-title":"Modulation of the antibiotic activity against multidrug resistant strains of coumarins isolated from Rutaceae species","volume":"104","author":"Madeiro","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2023.117187_b0670","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1039\/C4MD00196F","article-title":"Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: Reversing the resistance against frontline antibacterial drugs","volume":"5","author":"Joshi","year":"2014","journal-title":"Medchemcomm."},{"key":"10.1016\/j.bmc.2023.117187_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2022.100260","article-title":"Correlation between phytocompounds and pharmacological activities of Boerhavia diffusa Linn with traditional-ethnopharmacological insights","volume":"2","author":"Gaur","year":"2022","journal-title":"Phytomedicine Plus."},{"key":"10.1016\/j.bmc.2023.117187_b0680","first-page":"1","article-title":"Boeravinone B","volume":"8","author":"Singh","year":"2017","journal-title":"A Novel Dual Inhibitor of NorA Bacterial Efflux Pump of Staphylococcus aureus and Human P-Glycoprotein, Reduces the Biofilm Formation and Intracellular Invasion of Bacteria."},{"key":"10.1016\/j.bmc.2023.117187_b0685","first-page":"22","article-title":"In vitro e in silico evaluation of the inhibition of Staphylococcus aureus efflux pumps by caffeic and gallic acid","volume":"2018","author":"dos Santos","year":"2017","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2023.117187_b0690","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.micpath.2016.04.003","article-title":"Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus","volume":"97","author":"Tintino","year":"2016","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2023.117187_b0695","first-page":"3715","article-title":"Jatrorrhizine suppresses the antimicrobial resistance of methicillin-resistant Staphylococcus aureus","volume":"18","author":"Yu","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmc.2023.117187_b0700","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.micpath.2017.01.019","article-title":"Cholesterol and ergosterol affect the activity of Staphylococcus aureus antibiotic efflux pumps","volume":"104","author":"Tintino","year":"2017","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2023.117187_b0705","article-title":"Microbial Pathogenesis Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda","volume":"2020","author":"Maria","year":"2019","journal-title":"Microb Pthogenes."},{"issue":"6","key":"10.1016\/j.bmc.2023.117187_b0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antibiotics9060351","article-title":"Chalcones isolated from Arrabidaea brachypoda flowers as inhibitors of NorA and MepA multidrug efflux pumps of Staphylococcus aureus","volume":"9","author":"Rezende-J\u00fanior","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117187_b0715","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ijantimicag.2013.08.007","article-title":"A new plant-derived antibacterial is an inhibitor of efflux pumps in Staphylococcus aureus","volume":"42","author":"Shiu","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2023.117187_b0720","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00044-017-2063-y","article-title":"Vitamin K enhances the effect of antibiotics inhibiting the efflux pumps of Staphylococcus aureus strains","volume":"27","author":"Tintino","year":"2018","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2023.117187_b0725","first-page":"1","article-title":"Effect of vitamin K3 inhibiting the function of NorA efflux pump and its gene expression on Staphylococcus aureus","volume":"10","author":"Tintino","year":"2020","journal-title":"Membranes (Basel)."},{"key":"10.1016\/j.bmc.2023.117187_b0730","first-page":"50(April)","article-title":"Evaluation of Elaiophylin extracted from Streptomyces hygroscopicus as a potential inhibitor of the NorA efflux protein in Staphylococcus aureus: An in vitro and in silico approach","author":"dos Santos","year":"2021","journal-title":"Bioorganic Med Chem Lett."},{"key":"10.1016\/j.bmc.2023.117187_b0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.02153","article-title":"Microbe-Derived Indole Metabolite Demonstrates Potent Multidrug Efflux Pump Inhibition in Staphylococcus aureus","volume":"10","author":"Tambat","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2023.117187_b0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02635-16","article-title":"A New Natural Product Analog of Blasticidin S Reveals Cellular Uptake Facilitated by the NorA Multidrug Transporter","volume":"61","author":"Davison","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0745","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/jac\/dks232","article-title":"Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus","volume":"67","author":"Kalia","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105031","article-title":"1,3,4-oxadiazole conjugates of capsaicin as potent NorA efflux pump inhibitors of Staphylococcus aureus","volume":"113","author":"Naaz","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0755","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1039\/C5OB00246J","article-title":"Discovery of 4-acetyl-3-(4-fluorophenyl)-1-(p-tolyl)- 5-methylpyrrole as a dual inhibitor of human P-glycoprotein and Staphylococcus aureus Nor A efflux pump","volume":"13","author":"Bharate","year":"2015","journal-title":"Biomol Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0760","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1016\/j.bmc.2008.09.042","article-title":"Piperine analogs as potent Staphylococcus aureus NorA efflux pump inhibitors","volume":"16","author":"Sangwan","year":"2008","journal-title":"Bioorganic Med Chem."},{"key":"10.1016\/j.bmc.2023.117187_b0765","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jac\/dkn088","article-title":"Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus","volume":"61","author":"Kumar","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2023.117187_b0770","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1016\/j.bmcl.2016.07.062","article-title":"Amino acid amides of piperic acid (PA) and 4-ethylpiperic acid (EPA) as NorA efflux pump inhibitors of Staphylococcus aureus","volume":"26","author":"Wani","year":"2016","journal-title":"Bioorganic Med Chem Lett."},{"key":"10.1016\/j.bmc.2023.117187_b0775","first-page":"104","article-title":"Synthesis and Characterization of Piperine Analogs as Potent Staphylococcus aureus NorA Efflux Pump Inhibitors","volume":"3","author":"Chopra","year":"2019","journal-title":"Chem Methodol"},{"key":"10.1016\/j.bmc.2023.117187_b0780","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2174\/1573407215666190318125023","article-title":"Modification in the Natural Bioactive Molecule: Piperine; A Continuing Source for the Drug Development","volume":"16","author":"Chopra","year":"2020","journal-title":"Curr Bioact Compd"},{"key":"10.1016\/j.bmc.2023.117187_b0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103252","article-title":"Promising antibacterial agents against multidrug resistant Staphylococcus aureus","volume":"92","author":"Gatadi","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117187_b0790","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2006-959504","article-title":"Comparison of antibacterial and antifungal activities of lapachol and \u03b2-lapachone","volume":"60","author":"Guiraud","year":"1994","journal-title":"Planta Med"},{"key":"10.1016\/j.bmc.2023.117187_b0795","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104370","article-title":"Effect of hydroxyamines derived from lapachol and norlachol against Staphylococcus aureus strains carrying the NorA efflux pump","volume":"84","author":"Figueredo","year":"2020","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.bmc.2023.117187_b0800","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.phymed.2015.02.003","article-title":"Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives","volume":"22","author":"Cabral","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2023.117187_b0805","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2174\/138955712801264792","article-title":"Antioxidant and Antimicrobial Activities of Cinnamic Acid Derivatives","volume":"12","author":"Sova","year":"2012","journal-title":"Mini-Reviews Med Chem."},{"key":"10.1016\/j.bmc.2023.117187_b0810","volume":"Vol 19","author":"Guzman","year":"2014","journal-title":"Natural Cinnamic Acids, Synthetic Derivatives and Hybrids with Antimicrobial Activity."},{"key":"10.1016\/j.bmc.2023.117187_b0815","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.micpath.2018.08.022","article-title":"Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo","volume":"124","author":"Sundaramoorthy","year":"2018","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bmc.2023.117187_b0820","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bmc.2018.12.008","article-title":"Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus","volume":"27","author":"Rath","year":"2019","journal-title":"Bioorganic Med Chem."},{"key":"10.1016\/j.bmc.2023.117187_b0825","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ejmech.2018.03.028","article-title":"N, N\u2032-disubstituted cinnamamide derivatives potentiate ciprofloxacin activity against overexpressing NorA efflux pump Staphylococcus aureus 1199B strains","volume":"150","author":"Radix","year":"2018","journal-title":"Eur J Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:22:15Z","timestamp":1760836935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":165,"alternative-id":["S0968089623000354"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117187","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117187"}}